RTX (CPSE:RTX) Margin Gains Clash With Rich Valuation And Softer EPS

RTX stock closed at DKK102.5 heading into this earnings print after a flat 90 day stretch, and the fresh numbers tell a more charged story. The headline is margin. Management reported a gross margin of 54.8% and roughly 35% growth in earnings before interest, tax, depreciation and amortisation in the first nine months, which supported an upgraded full year profit outlook.

For short term traders the immediate question is whether that margin strength justifies RTX’s 71.1x trailing P/E. Long term holders may focus on whether the mix shift into Healthcare and ProAudio can keep that profitability trend intact over several years.

Is RTX a mispriced margin story, or is it simply carrying an expensive P/E that recent profits cannot support? Compare the rich multiple, trailing earnings, and DCF fair value in the valuation analysis for RTX.

Advertisement

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs Q3 2025): DKK 159.5m vs. DKK 146.9m (up about 9%)
  • Net Income (Excl. Extra Items, Q3 2026 vs Q3 2025): DKK 4.4m vs. DKK 5.2m (down about 16%)
  • Basic EPS (Q3 2026 vs Q3 2025): DKK 0.60 vs. DKK 0.65 (down about 8%)
  • Gross Margin (Q3 / 9M 2026 vs Prior Year): 54.8% for the latest period, compared with a level 4.1 percentage points lower a year earlier, indicating a wider margin

Prefer clean visuals over another dense page of earnings tables and P/E math? View RTX’s full financial picture, including how its profitability profile fits with the current valuation, in the interactive company report for RTX.

CPSE:RTX Trailing 12-Month Earnings & Revenue History as at Aug 2026
CPSE:RTX Trailing 12-Month Earnings & Revenue History as at Aug 2026

RTX margin story backed by mix and cash

For investors leaning optimistic, RTX gives some support. Revenue for the first nine months grew at about 8% in constant currency while gross margin reached 54.8%, helped by a higher share of Healthcare and ProAudio. EBITDA for the period rose about 35% and full year profit guidance moved higher, which points to improving earnings power on a relatively stable top line. A DKK 40m share buyback funded from cash of DKK 135m, above the stated target range, also signals a balance sheet that currently looks comfortable.

Short term execution risks still visible at RTX

The cautious view also finds material support. Q3 net income excluding extra items fell about 16% year on year and basic EPS slipped about 8%, even with stronger margins. Management flagged component shortages and order slippage between quarters, and also needs DKK 170m to DKK 200m revenue in Q4 to reach the upgraded guidance. That is achievable based on history but leaves little room for further disruption. The heavier R&D investment also needs to convert into sustained Enterprise, Healthcare and ProAudio demand.

With RTX showing a 2% net margin, negative trailing earnings and a 71.1x P/E, it is reasonable to question how robust the balance sheet really is. Check the full liquidity, debt and cash runway breakdown in the financial health analysis of RTX stock.

Stay Ahead With RTX And Simply Wall St

If RTX’s mix shift into Healthcare and ProAudio and its high P/E have caught your attention, register for free with Simply Wall St and add it to a Watchlist to track how the share price moves against fair value and earnings over time. Once you decide to take a position, organise your holdings with the Portfolio Command Center so you only see clear, focused updates that matter for your next move. For a broader view on RTX and similar stocks, use the Community to see what other investors are watching and debating. That way you can spot potential catalysts or emerging risks early and stay a step ahead of the market.

Seeking Alternatives Before The Crowd Moves

Fresh ideas do not stay quiet for long. Some stocks are already building breakout momentum while others are dropping off radars. Check these under the radar lists before the crowd, and consider reviewing them early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

MI
mitchell_lawler
mitchell_lawler

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it.

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it. cover
88
ZO
zoe_vi5fn

Any moat with an opt-out clause for your competitors is just a fence around your own garden.

CO
connor_iwn1g

Worth looking at what previous legal action actually did to Meta rather than reaching for tobacco. The FTC's record five billion dollar privacy fine in 2019 was met with the stock rising, because it came in below fears and removed an open question. GDPR was designed to constrain large platforms and increased their share of the European ad market, because compliance cost fell hardest on small intermediaries. The FTC's antitrust case, the one that could genuinely have broken the company up, was decided in Meta's favour last November. The only thing that ever meaningfully hurt the business was Apple changing a tracking default, and Meta out-spent that too, while the ad-tech firms that could not afford to rebuild disappeared. The pattern is not that Meta survives regulation. It is that regulation keeps costing its smaller competitors more.

Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
10

About CPSE:RTX

RTX

A technology company, designs, manufactures, and sells wireless communication solutions in Denmark, France, Germany, rest of Europe, the United States, Hong Kong, Other Asia and Pacific, and internationally.

Flawless balance sheet and slightly overvalued.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.575.7% undervalued
22 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5862.5% undervalued
59 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.0% undervalued
58 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11633.7% undervalued
11 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

LU
LunaRodas
FRO logo
LunaRodas on Frontline ·

FRO | Frontline: What They Said vs. What They Did

Fair Value:US$34.0728.4% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
JU
BBWI logo
julio on Bath & Body Works ·

BBWI VALUATION

Fair Value:US$39.7853.1% undervalued
23 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
JU
INTC logo
julio on Intel ·

INTC VALUATION

Fair Value:US$42.88114.8% overvalued
36 users have followed this narrative
2 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28018.6% undervalued
365 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.3% overvalued
213 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0946.1% undervalued
237 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative